Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

TVRD

Tvardi Therapeutics, Inc.

Healthcare · Pharmaceutical Preparations

$1.28Sep 29, 2026

AI confidence 71% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Tvardi Therapeutics, Inc. shows stable business momentum based on AlphaOS pipeline evidence.

TrajectoryStable

3 signals not yet derived from pipeline evidence

Pipeline evidence · 0d ago

TVRD's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on TVRD.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q1 2025

Full TVRD earnings analysis

Reported figures for Tvardi Therapeutics, Inc. — research only, not investment advice.

Revenue YoY
+20.1%

Latest Intelligence

Updated

What happened recently for Tvardi Therapeutics, Inc. (TVRD) — events, not interpretation.

Event
Reported Q1 2025 revenue +20% YoY.
Also
Last session September 29, 2026 at $1.28.
Source
Q1 2025 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Tvardi Therapeutics, Inc. (TVRD)

Healthcare · Pharmaceutical Preparations

Investment Snapshot above is the primary AlphaOS analysis for Tvardi Therapeutics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$17.07M
Revenue:
$2.57M

TVRD earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Tvardi Therapeutics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.